GlassScriptPhysician profile
Steven Baik
NPI 1912607839
$1,518.93
in general payments reported to CMS, 2019-2025
19 companies · $888 in 2025
The $888 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $631 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $538.39 | 2025 | Rapiblyk |
| Atricure, INC. | $302.71 | 2024 | |
| Novartis Pharmaceuticals Corporation | $118.45 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $91.58 | 2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $80.64 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.21 | 2024-2025 | Jardiance |
| Novo Nordisk INC | $38.25 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $36.96 | 2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.74 | 2024-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $36.42 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $29.88 | 2024 | |
| Abiomed | $27.22 | 2025 | |
| Cmp Pharma, INC. | $24.48 | 2025 | Atorvaliq, Liqrev, Norliqva |
| Merck Sharp & Dohme LLC | $24.16 | 2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $21.24 | 2025 | Assure Wcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $18.77 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $17.69 | 2025 | Amvuttra |
| Siemens Medical Solutions USA, INC. | $14.62 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Amgen INC. | $14.52 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Baik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.